Author

Fabrizia Suzzi

Observed name: Suzzi, Fabrizia <1992>

Institution: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Observed institutions: IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, University of Bologna

ORCID: 0000-0001-7632-064X

Observed ORCID: 0000-0001-7632-064X

OpenAlex ID: A5032476298

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area

2022 · Laura Gramantieri, Federica Gnudi, et al. · Nutrients · 35

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

2023 · Catia Giovannini, Fabrizia Suzzi, et al. · Cancers · 13

Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma

2023 · Laura Gramantieri, Fabrizia Suzzi, et al. · European Journal of Immunology · 12

Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies

2024 · Annapaola Montagner, Andrea Arleo, et al. · Biomolecules · 11

Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers

2021 · Laura Gramantieri, Catia Giovannini, et al. · Cancers · 11

Overcoming Immunotherapy Resistance in Small-Cell Lung Cancer

2026 · Matteo Canale, Fabrizia Suzzi, et al. · Biology · 1

Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC

2024 · Andrea Arleo, Annapaola Montagner, et al. · Biomolecules · 1

A simple characterization of dynamic changes in circulating CD8 +PD1+ lymphocytes early predicts response to atezolizumab-bevacizumab in hepatocellular carcinoma

2023 · Fabio Piscaglia, Fabrizia Suzzi, et al. · Journal of Hepatology

Works count: 9

Citation count: 84

H-index: 5

I10-index: 5